US Edition
Stephen Saad’s Aspen stake drops $21 million in value
Summary by Billionaires.Africa
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Stephen Saad’s Aspen stake drops $21 million in value
Key PointsStephen Saad's fortune dips as Aspen shares fall 5.33% in 10 days, erasing $21.42 million from his stake.Year-to-date, shares have plunged 27.83%, underperforming the JSE Top 40 and global pharma peers amid rising interest rates.Regulatory hurdles, weak sentiment, and margin pressure shrink Aspen’s market cap to $3 billion, deepening shareholder losses.Stephen Saad, CEO of Aspen Pharmacare—Africa’s largest drug manufacturer—has faced a…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
